Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,401–6,425 of 7,816 matching trials · page 257 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Effects of Horticultural Therapy on Elderly at Risk of Cognitive Decline NCT03045718 Horticultural Therapy Runs in: Singapore · 1 site |
NA other |
UNKNOWN | 100 | National University Hospital, Singapore OTHER |
2017-02-07 |
|
Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects NCT02546310 HTL0009936; HTL0009936 matching placebo Runs in: United Kingdom · 1 site |
PHASE1 other |
COMPLETED | 54 | Nxera Pharma UK Limited INDUSTRY |
2017-02-03 |
|
Intervention Program for Patients With Mild Cognitive Impairment NCT02670850 Family Caregiver Intervention Program Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 60 | Chang Gung Memorial Hospital OTHER |
2017-02-03 |
|
The Effect of Movement-oriented Dementia Care on ADL and QoL of Dementia Patients in Nursing Homes NCT03001232 Movement-oriented Dementia Care |
NA other |
COMPLETED | 66 | VU University of Amsterdam OTHER |
2017-02-03 |
|
Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals NCT02503462 Darunavir; ritonavir; cobicistat Runs in: Switzerland · 1 site |
PHASE4 other |
TERMINATED | 7 | University Hospital, Basel, Switzerland OTHER |
2017-02-02 |
|
Isotopic Imaging for Prodromal Alzheimer's Disease NCT01231295 Runs in: France · 25 sites |
NA other |
COMPLETED | 143 | Centre Hospitalier Universitaire de Nīmes OTHER |
2017-02-01 |
|
Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults NCT02051335 Roflumilast; Roflumilast placebo; Donepezil; Donepezil placebo; Scopolamine Runs in: United Kingdom · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 27 | AstraZeneca INDUSTRY |
2017-02-01 |
|
Health Care Courses of Elderly Hospitalized Patients for Inappropriate Reasons: Qualitative and Economic Analyzes NCT02749669 Qualitative research Runs in: France · 1 site |
NA other |
COMPLETED | 22 | Régis AUBRY OTHER |
2017-02-01 |
|
The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study NCT03038035 MLC901; Placebo Runs in: Singapore · 1 site |
PHASE2 other |
UNKNOWN | 150 | National University Hospital, Singapore OTHER |
2017-01-31 |
|
Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients NCT03038282 Chromium Chloride; Individual Exercise |
NA other |
UNKNOWN | 100 | Metabolic Therapy Inc. OTHER |
2017-01-31 |
|
Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease NCT03038334 Magnesium sulfate |
NA other |
UNKNOWN | 100 | Metabolic Therapy Inc. OTHER |
2017-01-31 |
|
Impact of Physical Activity on Successful Aging NCT03034746 Physical activity (PA); cognitive treatment (CT) |
NA other |
COMPLETED | 90 | Universita di Verona OTHER |
2017-01-30 |
|
Application and Revision of Montreal Cognitive Assessment in Chinese Retirees NCT02483754 |
NA other |
COMPLETED | 304 | Xijing Hospital OTHER |
2017-01-26 |
|
Safety Study of Nicotinamide to Treat Alzheimer's Disease NCT00580931 Nicotinamide; Enduramide placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 50 | University of California, Irvine OTHER |
2017-01-25 |
|
Scalp Nerve Block on Emergence Agitation NCT02428283 Ropivacaine; Remifentanil; Sevoflurane Runs in: South Korea · 1 site |
PHASE4 other |
COMPLETED | 44 | Ajou University School of Medicine OTHER |
2017-01-25 |
|
Orientation in AD Patients: PET-MR Study NCT03030365 Siemens "Biograph mMR" PET-MR (3T) |
NA other |
UNKNOWN | 30 | Assuta Medical Center OTHER |
2017-01-25 |
|
Acupuncture for the Prevention of Emergence Delirium in Children Undergoing Myringotomy Tube Placement NCT02383004 Acupuncture Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | Oregon Health and Science University OTHER |
2017-01-18 |
|
BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects NCT02648672 BPN14770; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 32 | Tetra Discovery Partners INDUSTRY |
2017-01-18 |
|
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program NCT02746484 Ability platform program; Usual care program |
NA other |
COMPLETED | 30 | Fondazione Don Carlo Gnocchi ETS OTHER |
2017-01-18 |
|
Triglyceride-rich Lipoprotein and Development of Dementia NCT02814422 Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 1,000 | National Taiwan University Hospital OTHER |
2017-01-18 |
|
A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects NCT02840279 BPN14770; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 77 | Tetra Discovery Partners INDUSTRY |
2017-01-18 |
|
Validation of the French Version of the Geriatric Mental State (GMS) NCT01061827 Runs in: France · 2 sites |
NA other |
COMPLETED | 96 | University Hospital, Tours OTHER |
2017-01-16 |
|
Remote Ischemic Preconditioning for Subcortical Vascular Dementia NCT03022149 Doctormate® (200mmHg); Doctormate® (60mmHg) Runs in: China · 1 site |
NA other |
UNKNOWN | 52 | Tianjin Medical University General Hospital OTHER |
2017-01-16 |
|
Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants NCT02782975 aducanumab Runs in: United States · 2 sites |
PHASE1 anti-amyloid-antibody |
COMPLETED | 28 | Biogen INDUSTRY |
2017-01-13 |
|
Effects of Fatty Acid Supplementation on Substance Dependent Individuals NCT00312455 Pro-eicosapentaenoic acid (EPA); Pro-docosapentaenoic acid (DPA); Placebo |
PHASE2 other |
COMPLETED | — | National Institute on Drug Abuse (NIDA) NIH |
2017-01-12 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial